Read our latest news

Press releases

Jan30

Solid Biosciences Inc. (NASDAQ:SLDB), announced today the closing of its initial public offering of 8,984,375 shares of its common stock, sold by the Company at a public offering price of $16.00 per share.

Jan25

Solid Biosciences Inc. (NASDAQ:SLDB) today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a price to the public of $16.00 per share, for total gross proceeds of approximately $125,000,000.

Nov30

Phase I/II adaptive clinical trial to evaluate safety and efficacy in ambulatory and non-ambulatory children and adolescents.

View our media

Gus

Gus (10) Peterborough, NH

Gals for Cal, women's triathlon 2016

Gals for Cal, women's triathlon 2016

Gals for Cal, women's triathlon 2016

Solid Mission

Solid Organization

Solid Community

Charity Collaboration

Contact information

Kate Niazi-Sai
Senior Director, Corporate Affairs 
media@solidbio.com

More information about Solid?

Please subscribe to receive our latest news